Cargando…

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy

Concurrent chemo-radiotherapy is a commonly employed curative treatment approach for locally advanced cancers but is associated with considerable morbidity. Chemo-radiotherapy using proton therapy may be able to reduce side effects of treatment and improve efficacy, but this remains an area of contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumann, Brian C., Hallahan, Dennis E., Michalski, Jeff M., Perez, Carlos A., Metz, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493883/
https://www.ncbi.nlm.nih.gov/pubmed/32555364
http://dx.doi.org/10.1038/s41416-020-0919-2
_version_ 1783582647109287936
author Baumann, Brian C.
Hallahan, Dennis E.
Michalski, Jeff M.
Perez, Carlos A.
Metz, James M.
author_facet Baumann, Brian C.
Hallahan, Dennis E.
Michalski, Jeff M.
Perez, Carlos A.
Metz, James M.
author_sort Baumann, Brian C.
collection PubMed
description Concurrent chemo-radiotherapy is a commonly employed curative treatment approach for locally advanced cancers but is associated with considerable morbidity. Chemo-radiotherapy using proton therapy may be able to reduce side effects of treatment and improve efficacy, but this remains an area of controversy and data are relatively limited. We comment on recently published studies and discuss future directions for proton therapy.
format Online
Article
Text
id pubmed-7493883
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74938832021-06-18 Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy Baumann, Brian C. Hallahan, Dennis E. Michalski, Jeff M. Perez, Carlos A. Metz, James M. Br J Cancer Comment Concurrent chemo-radiotherapy is a commonly employed curative treatment approach for locally advanced cancers but is associated with considerable morbidity. Chemo-radiotherapy using proton therapy may be able to reduce side effects of treatment and improve efficacy, but this remains an area of controversy and data are relatively limited. We comment on recently published studies and discuss future directions for proton therapy. Nature Publishing Group UK 2020-06-18 2020-09-15 /pmc/articles/PMC7493883/ /pubmed/32555364 http://dx.doi.org/10.1038/s41416-020-0919-2 Text en © Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Comment
Baumann, Brian C.
Hallahan, Dennis E.
Michalski, Jeff M.
Perez, Carlos A.
Metz, James M.
Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
title Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
title_full Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
title_fullStr Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
title_full_unstemmed Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
title_short Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
title_sort concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493883/
https://www.ncbi.nlm.nih.gov/pubmed/32555364
http://dx.doi.org/10.1038/s41416-020-0919-2
work_keys_str_mv AT baumannbrianc concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy
AT hallahandennise concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy
AT michalskijeffm concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy
AT perezcarlosa concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy
AT metzjamesm concurrentchemoradiotherapywithprotontherapyreducedtoxicitywithcomparableoncologicaloutcomesvsphotonchemoradiotherapy